Alnylam Pharmaceuticals ALNY Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $205.99M+84.7% | $111.54M-55.6% | $251.08M+479% | -$66.28M-263% | -$18.25M+78.2% | ||
| $13.55M+0.3% | $13.51M-2.2% | $13.8M-1.0% | $13.94M-3.2% | $14.41M+1.7% | ||
| $70.15M-2.1% | $71.63M-33.8% | $108.21M-3.1% | $111.68M+96.9% | $56.71M-38.1% | ||
| $70.5M-56.9% | $163.56M-49.7% | $325.11M+109% | $155.73M+229% | -$120.31M-27.1% | ||
| $21.83M-6.3% | $23.29M+91.8% | $12.14M-15.0% | $14.29M+59.3% | $8.97M-1.4% | ||
| -$25.54M— | $0-100% | $501.11M+454% | -$141.38M-224% | $113.77M+315% | ||
| $15.71M— | —— | -$448.35M-966% | $51.76M+12.3% | $46.08M+48.7% | ||
| $53.61M-67.7% | $166.01M-56.0% | $376.94M+303% | $93.61M+74.7% | $53.6M— | ||
| $48.67M-65.3% | $140.26M-55.2% | $312.97M+121% | $141.44M+209% | -$129.28M-24.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Alnylam Pharmaceuticals generate?
- Alnylam Pharmaceuticals (ALNY) generated $714.9M in operating cash flow over the trailing twelve months.
- What is Alnylam Pharmaceuticals's free cash flow?
- After $71.6M of capital expenditures, Alnylam Pharmaceuticals's free cash flow was $643.3M over the trailing twelve months, up 931.4% year over year.
- Where does Alnylam Pharmaceuticals's cash flow data come from?
- Every line is extracted from Alnylam Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
